Mortality rates for ebola outbreak vary by strand of virus between roughly 60% and 90%. This outbreak is so far on the lower end of the scale, so having a drug that reliably safes 30% and kills 70% would be a loss, whereas in other cases it might be a win. Untested drug, things can go wrong and you're giving it to people that are already in very bad shape.